Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marvell Technology Inc (MRVL) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance

Marvell Technology IncTrade
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade

Price performance (Past 24H)

Key statistics

Marvell Technology Inc vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Marvell Technology Inc trades at $240.16 (market cap $241.50B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $36.73 (market cap $63.57B). The key difference: Marvell Technology Inc is far larger — about 3.8× RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)'s market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.49%). Which is the better fit depends on your goals.

MRVLRELX
Market Cap
$241.50B$63.57B
Volume
18,287,9071,602,093
Sector
TechnologyIndustrials
52-Week High
$316.43$46.80
52-Week Low
$73.73$27.73
Typical Hold Time
43 Days—
Enterprise Value
$242.86B$75.05B
Dividend Yield
0.09%2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marvell Technology Inc

Marvell Technology (MRVL) trades at $245.28, down 7.74% over 24 hours, with a bullish technical signal from moving averages and a consensus analyst price target of $327.86 implying significant upside. The company reported three consecutive quarterly EPS beats, with Q3 2026 expected at $1.1, and projects robust revenue growth, particularly in its custom AI chip business, which is forecast to more than double by fiscal 2028. Despite a net loss in 2025, improving operating cash flow and a strong gross margin of 52.21% highlight underlying operational strength.

The outlook for MRVL is positive, driven by AI-driven demand in data centers and custom silicon deals with hyperscalers like Google, though high valuation multiples (P/E of 88.98) and execution risks in scaling custom chip production pose challenges. Investor sentiment remains bullish, with 83.79% of analysts rating the stock a buy, but volatility near all-time highs and competitive pressures warrant caution.

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRVL
47% Buy53% Sell
Avg holding period · 43 Days
RELX

No sentiment data available yet.

Top news

Latest headlines on both assets

About Marvell Technology Inc

Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.

Read more on MRVL →

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →